Skip to Main Content

Advertisement

Close

AACR Journals
For Authors
About Us
Article Collections
COVID-19
Webinars

header search

search input Search input auto suggest

Search

Advanced Search

Menu

About
Articles
For Authors
Alerts
News
COVID-19
Webinars

Skip Nav Destination

Issues

Select Year

Issue

Volume 7, Issue 11

1 November 2001

ISSN 1078-0432

EISSN 1557-3265

Issue Sections

Editorial
Minireview
The Biology Behind
Advances in Brief
- Molecular Oncology, Markers, Clinical Correlates
- Experimental Therapeutics, Preclinical Pharmacology
Regular Articles
- Clinical Trials
Research Articles
- Molecular Oncology, Markers, Clinical Correlates
- Experimental Therapeutics, Preclinical Pharmacology

Editorial

Thalidomide, Cyclooxygenase-2, and Angiogenesis: Potential for Therapy

Amir Onn; Jennifer E. Tseng; Roy S. Herbst

Minireview

Strategies for Enzyme/Prodrug Cancer Therapy 1

Guang Xu; Howard L. McLeod

The Biology Behind

A Proteomics Approach to Find a New Breast Cancer-specific Antigenic Marker: Commentary re: Protemics-based Identification of RS/DJ-1 as a Novel Circulating Tumor Antigen in Breast Cancer. Clin. Cancer Res., 7: 3328–3335, 2001.

Ryuji Kobayashi

Advances in Brief

Molecular Oncology, Markers, Clinical Correlates

Proteomics-based Identification of RS/DJ-1 as a Novel Circulating Tumor Antigen in Breast Cancer 1

François Le Naour; David E. Misek; Melissa C. Krause; L. Deneux; Thomas J. Giordano; S. Scholl; Samir M. Hanash

Experimental Therapeutics, Preclinical Pharmacology

The Investigational New Drug XK469 Induces G₂-M Cell Cycle Arrest by p53-dependent and -independent Pathways 1

Zhenhua Ding; Ralph E. Parchment; Patricia M. LoRusso; Jun-Ying Zhou; Jun Li; Theodore S. Lawrence; Yi Sun; Gen Sheng Wu

Characterization of HLA-A3-restricted Cytotoxic T Lymphocytes Reactive against the Widely Expressed Tumor Antigen Telomerase 1

Robert H. Vonderheide; Karen S. Anderson; William C. Hahn; Mark O. Butler; Joachim L. Schultze; Lee M. Nadler

Thalidomide and Its Analogues Inhibit Lipopolysaccharide-mediated Induction of Cyclooxygenase-2 1

Junya Fujita; Juan R. Mestre; Jerome B. Zeldis; Kotha Subbaramaiah; Andrew J. Dannenberg

Regular Articles

Clinical Trials

A Randomized Clinical Trial of 4-Hydroxyphenylretinamide for High-Grade Squamous Intraepithelial Lesions of the Cervix 1

Michele Follen; E. Neely Atkinson; David Schottenfeld; Anais Malpica; Loyd West; Scott Lippman; Changping Zou; Walter N. Hittelman; Reuben Lotan; Waun Ki Hong

Tissue Examination to Monitor Antiangiogenic Therapy: A Phase I Clinical Trial with Endostatin 1

Christoph Mundhenke; James P. Thomas; George Wilding; Fred T. Lee; Fred Kelzc; Rick Chappell; Rosemary Neider; Linda A. Sebree; Andreas Friedl

Phase II Trial of Cisplatin, Interferon α-2b, Doxorubicin, and 5-Fluorouracil for Biliary Tract Cancer 1

Yehuda Z. Patt; Manal M. Hassan; Richard D. Lozano; Kimberly A. Waugh; Ashraful M. Hoque; Adam I. Frome; Sandeep Lahoti; Lee Ellis; J. Nicolas Vauthey; Steven A. Curley; Isac I. Schnirer; Isaac Raijman

Cancer Biology, Immunology, Cytokines

MCF-10A-NeoST: A New Cell System for Studying Cell-ECM and Cell-Cell Interactions in Breast Cancer 1

Nicole Dodge Zantek; Jennifer Walker-Daniels; Jane Stewart; Rhonda K. Hansen; Daniel Robinson; Hui Miao; Bingcheng Wang; Hsing-Jien Kung; Mina J. Bissell; Michael S. Kinch

Research Articles

Molecular Oncology, Markers, Clinical Correlates

Vascular Endothelial Growth Factor in Newly Diagnosed and Recurrent Childhood Acute Lymphoblastic Leukemia as Measured by Real-Time Quantitative Polymerase Chain Reaction

Reet Koomagi; Felix Zintl; Axel Sauerbrey; Manfred Volm

Nitric Oxide, Prostanoids, Cyclooxygenase, and Angiogenesis in Colon and Breast Cancer 1

Richard J. Bing; Masaru Miyataka; Kathryn A. Rich; Nicholas Hanson; Xuedong Wang; Henry D. Slosser; Shan-Rong Shi

Analysis of Normal Epithelial Cell Specific-1 (NES1)/Kallikrein 10 mRNA Expression by in Situ Hybridization, a Novel Marker for Breast Cancer 1

Sanjay Dhar; Rohit Bhargava; Michael Yunes; Biao Li; Jaya Goyal; Stephen P. Naber; David E. Wazer; Vimla Band

Hypoxia-regulated Carbonic Anhydrase-9 (CA9) Relates to Poor Vascularization and Resistance of Squamous Cell Head and Neck Cancer to Chemoradiotherapy

Michael I. Koukourakis; Alexandra Giatromanolaki; Efthimios Sivridis; Konstantinos Simopoulos; Jaromir Pastorek; Charles C. Wykoff; Kevin C. Gatter; Adrian L. Harris

Chromosome 6 Abnormalities in Ovarian Surface Epithelial Tumors of Borderline Malignancy Suggest a Genetic Continuum in the Progression Model of Ovarian Neoplasms 1

Maria Grazia Tibiletti; Barbara Bernasconi; Daniela Furlan; Paola Bressan; Roberta Cerutti; Carla Facco; Massimo Franchi; Cristina Riva; Raffaella Cinquetti; Carlo Capella; Roberto Taramelli

Evaluation of Angiogenesis in Non-small Cell Lung Cancer: Comparison between Anti-CD34 Antibody and Anti-CD105 Antibody 1

Fumihiro Tanaka; Yosuke Otake; Kazuhiro Yanagihara; Yozo Kawano; Ryo Miyahara; Mio Li; Tomoko Yamada; Nobuharu Hanaoka; Kenji Inui; Hiromi Wada

Single Nucleotide Polymorphisms in the Human Reduced Folate Carrier: Characterization of a High-Frequency G/A Variant at Position 80 and Transport Properties of the His²⁷ and Arg²⁷ Carriers 1

Johnathan R. Whetstine; Andrew J. Gifford; Teah Witt; Xiang Y. Liu; Robin M. Flatley; Murray Norris; Michelle Haber; Jeffrey W. Taub; Y. Ravindranath; Larry H. Matherly

Quantitative Reverse Transcription-Polymerase Chain Reaction Detection of Cytokeratin 20 in Noncolorectal Lymph Nodes 1

Richie Soong; Kurt Beyser; Oliver Basten; Andreas Kalbe; Josef Rueschoff; Karim Tabiti

Inverse Correlation of Thioredoxin Expression with Estrogen Receptor- and p53-dependent Tumor Growth in Breast Cancer Tissues 1

Yasuo Matsutani; Akira Yamauchi; Rei Takahashi; Masaya Ueno; Kiyotugu Yoshikawa; Kazuo Honda; Hajime Nakamura; Hironori Kato; Hiroshi Kodama; Takashi Inamoto; Junji Yodoi; Yoshio Yamaoka

Expression of METH-1 and METH-2 in Pancreatic Cancer 1

Toshihiko Masui; Ryo Hosotani; Shoichiro Tsuji; Yoshiharu Miyamoto; Seichi Yasuda; Jun Ida; Sanae Nakajima; Michiya Kawaguchi; Hiroyuki Kobayashi; Masayuki Koizumi; Eiji Toyoda; Sidhartha Tulachan; Shigeki Arii; Ryuichiro Doi; Masayuki Imamura

Microsatellite Instability in Thyroid Cancer: Hot Spots, Clinicopathological Implications, and Prognostic Significance 1

Masamitsu Onda; Izumi Nakamura; Shinichi Suzuki; Seiichi Takenoshita; Carl-Henrik Brogren; Sabina Stampanoni; Daisy Li; Nicholas Rampino

Prognostic Significance of Matrix Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-1 in Voided Urine Samples from Patients with Transitional Cell Carcinoma of the Bladder 1

Garrett C. Durkan; Joyce E. Nutt; Paul H. Rajjayabun; David E. Neal; John Lunec; J. Kilian Mellon

Expression Levels of the Nerve Growth Factor Receptors TrkA and p75 in Effusions and Solid Tumors of Serous Ovarian Carcinoma Patients 1

Ben Davidson; Philip Lazarovici; Alexandra Ezersky; Jahn M. Nesland; Aasmund Berner; Bjørn Risberg; Claes G. Tropé; Gunnar B. Kristensen; Mariusz Goscinski; Gregg van de Putte; Reuven Reich

Association of E-Cadherin Germ-Line Alterations with Prostate Cancer 1

Tarja Ikonen; Mika Matikainen; Nina Mononen; Eija-R. Hyytinen; Heikki J. Helin; Satu Tommola; Teuvo L. J. Tammela; Eero Pukkala; Johanna Schleutker; Olli-P. Kallioniemi; Pasi A. Koivisto

Decreased Androgen-responsive Growth of Human Prostate Cancer Is Associated with Increased Genetic Alterations 1

Dev Karan; Bruno M. Schmied; Bhavana J. Dave; Uwe A. Wittel; Ming-Fong Lin; Surinder K. Batra

p16/p14^ARF Cell Cycle Regulatory Pathways in Primary Neuroblastoma: p16 Expression Is Associated with Advanced Stage Disease 1

Motoko Omura-Minamisawa; Mitchell B. Diccianni; Ray C. Chang; Ayse Batova; Louis J. Bridgeman; Jessica Schiff; Susan L. Cohn; Wendy B. London; Alice L. Yu

Serum Vascular Endothelial Growth Factor in Breast Cancer: Its Relation with Cancer Type and Estrogen Receptor Status 1

Kamal Heer; Harish Kumar; John R. Read; John N. Fox; John R. T. Monson; Michael J. Kerin

Altered Subcellular Localization of Suppressin, a Novel Inhibitor of Cell-Cycle Entry, Is an Independent Prognostic Factor in Colorectal Adenocarcinomas

Upender Manne; Bernard D. Gary; Denise K. Oelschlager; Heidi L. Weiss; Andra R. Frost; William E. Grizzle

Prognostic Value of Serum Biological Markers in Patients with Hepatocellular Carcinoma 1

Rosanna Parasole; Francesco Izzo; Francesco Perrone; Sandro Pignata; Maria Giulia Galati; Enrico Leonardi; Fabiana Castiglione; Raffaele Orlando; Giuseppe Castello; Giuseppe Esposito; Ciro Gallo; Bruno Daniele

Apurinic/Apyrimidinic Endonuclease Activity Is Elevated in Human Adult Gliomas 1

Michael S. Bobola; A. Blank; Mitchel S. Berger; Bobby A. Stevens; John R. Silber

Profiling of Differentially Expressed Cancer-related Genes in Esophageal Squamous Cell Carcinoma (ESCC) Using Human Cancer cDNA Arrays: Overexpression of Oncogene MET Correlates with Tumor Differentiation in ESCC

Ying Chuan Hu; King Yin Lam; Simon Law; John Wong; Gopesh Srivastava

Overrepresentation of the EBAG9 Gene at 8q23 Associated with Early-Stage Breast Cancers 1

Michiko Tsuneizumi; Mitsuru Emi; Hisaki Nagai; Haruhito Harada; Goi Sakamoto; Fujio Kasumi; Satoshi Inoue; Teruhisa Kazui; Yusuke Nakamura

Experimental Therapeutics, Preclinical Pharmacology

Characterization of a Thymidylate Synthase (TS)-inducible Cell Line: A Model System for Studying Sensitivity to TS- and non-TS-targeted Chemotherapies 1

Daniel B. Longley; Paul R. Ferguson; John Boyer; Tariq Latif; Maria Lynch; Pamela Maxwell; D. Paul Harkin; Patrick G. Johnston

Implication of Macrophages in Tumor Rejection Induced by CpG-oligodeoxynucleotides Without Antigen 1

Gregor Auf; Antoine F. Carpentier; Lin Chen; Christelle Le Clanche; Jean-Yves Delattre

Preclinical Antitumor Activity and Pharmacodynamic Studies with the Farnesyl Protein Transferase Inhibitor R115777 in Human Breast Cancer

Lloyd R. Kelland; Vicki Smith; Melanie Valenti; Lisa Patterson; Paul A. Clarke; Simone Detre; Dave End; Angela J. Howes; Mitch Dowsett; Paul Workman; Stephen R. D. Johnston

Antitumor Efficacy in Vitro and in Vivo of Falconensones, a New Type of Polyene 1

Kayoko Tamagawa; Kazuyuki Shimizu; Takuya Ebine; Yoshie Maitani; Tetsuya Fukui; Ken-ichi Kawai; Noriko Takahashi

Resistance to 2-Chloro-2′-deoxyadenosine of the Human B-cell Leukemia Cell Line EHEB 1

Sabine Cardoen; Eric Van Den Neste; Caroline Smal; Jean-François Rosier; Anne Delacauw; Augustin Ferrant; Georges Van den Berghe; Françoise Bontemps

Anticancer Effect of a Lentiviral Vector Capable of Expressing HIV-1 Vpr

Shen Pang; Mo K. Kang; Sam Kung; Duan Yu; Annie Lee; Betty Poon; Irvin S. Y. Chen; Bob Lindemann; No-Hee Park

Inhibition of Malignant Cell Growth by 311, a Novel Iron Chelator of the Pyridoxal Isonicotinoyl Hydrazone Class: Effect on the R2 subunit of Ribonucleotide Reductase

Dena A. Green; William E. Antholine; Stuart J. Wong; Des R. Richardson; Christopher R. Chitambar

DNA Repair Initiated in Chronic Lymphocytic Leukemia Lymphocytes by 4-Hydroperoxycyclophosphamide Is Inhibited by Fludarabine and Clofarabine 1

Takahiro Yamauchi; Billie J. Nowak; Michael J. Keating; William Plunkett

E2F-1 Up-Regulates c-Myc and p14^ARF and Induces Apoptosis in Colon Cancer Cells 1

Mary Jane Elliott; Yan Bin Dong; Hailiang Yang; Kelly M. McMasters

Prevention of Human Prostate Tumor Metastasis in Athymic Mice by Antisense Targeting of Human Angiogenin 1

Karen A. Olson; H. Randolph Byers; Marc E. Key; James W. Fett

Tumor Targeting and Imaging of Intraperitoneal Tumors by Use of Antisense Oligo-DNA Complexed with Dendrimers and/or Avidin in Mice 1

Noriko Sato; Hisataka Kobayashi; Tsuneo Saga; Yuji Nakamoto; Takayoshi Ishimori; Kaori Togashi; Yasuhisa Fujibayashi; Junji Konishi; Martin W. Brechbiel

Antisense Anti-MDM2 Oligonucleotides As a Novel Therapeutic Approach to Human Breast Cancer: In Vitro and in Vivo Activities and Mechanisms 1

Hui Wang; Li Nan; Dong Yu; Sudhir Agrawal; Ruiwen Zhang

Systemic Vector Leakage and Transgene Expression by Intratumorally Injected Recombinant Adenovirus Vectors 1

Frank Lohr; Qian Huang; Kang Hu; Mark W. Dewhirst; Chuan-Yuan Li

Bimodal Effects of 1R,2R-Diaminocyclohexane(trans-diacetato)(dichloro)platinum(IV) on Cell Cycle Checkpoints 1

Jian Kuang; Guangan He; Zaifeng Huang; Abdul R. Khokhar; Zahid H. Siddik

Advertisement

Email alerts

Online First Alert

eTOC Alert

Latest
Most Read
Most Cited

Stress Keratin 17 Expression in Head and Neck Cancer Contributes to Immune Evasion and Resistance to Immune-Checkpoint Blockade

Molecular Pathways and Mechanisms of LAG-3 in Cancer Therapy

First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response

Patient-derived Organoids Pharmacotyping Guides Precision Medicine for Pancreatic Cancer

Issues
Online First
Collections

News
Twitter

Online ISSN 1557-3265
Print ISSN 1078-0432

AACR Journals

Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers, & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics

Info for Advertisers
Info for Librarians
Privacy Policy

Twitter
LinkedIn
Facebook
Youtube

Copyright © 2022 by the American Association for Cancer Research.

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.

Accept